Position in VTRS
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$10,580,140
-$33,924,675 QoQ
Shares Held
783,134
-78.1% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Assenagon Asset Management S.A. holds $291,766,020 across 19 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
815,412 | $96,389,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,339,702 | $40,351,824 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,067,361 | $38,127,297 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
47,183 | $27,978,575 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
530,618 | $27,427,644 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
91,478 | $12,051,311 | |
| 7 | VTRS |
Viatris Inc
This page
|
783,134 | $10,580,140 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
312,598 | $10,337,615 |
All Filings in VTRS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,580,140 | 783,134 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $44,504,815 | 3,574,684 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $8,707,327 | 879,528 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $35,473,987 | 3,972,451 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $6,167,429 | 708,086 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,786,566 | 625,427 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $10,758,510 | 926,659 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $7,840,103 | 737,545 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $9,679,531 | 810,681 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $24,889,072 | 2,298,160 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $7,269,393 | 737,261 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $3,461,882 | 346,882 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $12,520,295 | 1,301,486 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,693,744 | 1,769,429 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $15,612,942 | 1,832,505 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $22,670,240 | 2,165,257 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,832,074 | 260,301 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,325,141 | 97,941 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $52,742,724 | 3,892,452 | Shares | Sole | 2021-10-19 | |
| No filing history on record for this holder in this stock. | ||||||